Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 34,109,000 | 33,306,000 | 35,957,000 | 35,058,000 | 32,035,000 |
| Cost of Goods | 11,029,000 | 10,990,000 | 11,118,000 | 10,902,000 | 8,717,000 |
| Gross Profit | 23,080,000 | 22,316,000 | 24,839,000 | 24,156,000 | 23,318,000 |
| Operating Expenses | 16,249,000 | 15,837,000 | 17,052,000 | 16,969,000 | 15,985,000 |
| Operating Income | 6,831,000 | 6,479,000 | 7,787,000 | 7,187,000 | 7,333,000 |
| Interest Expense | 605,000 | 612,000 | 553,000 | 552,000 | 467,000 |
| Other Income | -495,000 | -1,264,000 | -1,357,000 | -1,316,000 | -1,267,000 |
| Pre-tax Income | 5,731,000 | 4,603,000 | 5,877,000 | 5,319,000 | 5,599,000 |
| Income Tax | 1,171,000 | 763,000 | 1,134,000 | 455,000 | 1,242,000 |
| Net Income Continuous | 4,509,000 | 3,875,000 | 5,136,000 | 5,934,000 | 5,335,000 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 386,000 |
| Minority Interests | -119,000 | -158,000 | -169,000 | -241,000 | -254,000 |
| Net Income | $4,390,000 | $3,717,000 | $4,967,000 | $5,693,000 | $5,467,000 |
| EPS Basic Total Ops | 3.34 | 2.81 | 3.76 | 4.31 | 4.19 |
| EPS Basic Continuous Ops | 3.34 | 2.81 | 3.76 | 4.31 | 4.19 |
| EPS Diluted Total Ops | 3.30 | 2.78 | 3.74 | 4.29 | 4.18 |
| EPS Diluted Continuous Ops | 3.30 | 2.78 | 3.74 | 4.29 | 4.18 |
| EBITDA(a) | $10,113,000 | $10,784,000 | $11,337,000 | $11,424,000 | $11,195,000 |